High expression of FN1 was observed in cervical cancer, hepatocellular carcinoma, ovarian cancer, and esophageal cancer (Helleman et al., 2006; Xu et al., 2015; Song et al., 2017; Wang et al., 2019). Here, FN1 is linked to hepatocellular carcinoma.